Director, Global Value & Access Strategy (Cell-Therapy Autoimmune)
Core
Director leading global market access, value demonstration, and evidence generation strategies for Kite's autoimmune cell therapy portfolio.
Role type
Senior IC Director, Global Value & Access Strategy
Builds
Global market access strategies, evidence generation plans, and value propositions for cell therapy products
Domain
Biotechnology / Cell Therapy / Autoimmune Diseases
Required skills
Global market access strategy, Health Economics and Outcomes Research (HEOR), Real-World Evidence (RWE), Payer engagement, HTA strategy, Clinical development planning, Pricing strategy, Reimbursement strategy, Cross-functional leadership, Strategic planning
Preferred skills
Autoimmune disease program experience, Cell/gene therapy experience, Launch readiness planning, Global payer landscape knowledge, Value framework expertise, Cross-functional influence
Technologies
None stated
Responsibilities
Lead development of global value and access strategies across the product lifecycle; Partner with Clinical, HEOR, and Medical Affairs to develop evidence generation strategies; Analyze market access trends and competitive dynamics across major global markets; Advise development teams on evidence requirements for reimbursement and pricing; Lead cross-functional assessment of payer and HTA evidence requirements; Influence strategic decisions regarding development plans and launch readiness.
Seniority
Senior, hands-on IC
